Lanosterol
Specifications
79-63-0CAS Number
201-214-9EC Number
(3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-olIUPAC Name
C30H50OChemical Formula
426.7 g/molMolecular Weight
lanosterol; 79-63-0; Lanosterin; (3beta)-lanosta-8,24-dien-3-ol; Lanosta-8,24-dien-3beta-ol; Kryptosterol; Lanosta-8,24-dien-3-ol, (3beta)-; DTXSID1040744; CHEBI:16521; 1J05Z83K3M; NSC-60677; (3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; 4,4',14alpha-Trimethyl-5alpha-cholesta-8,24-dien-3beta-ol; (3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-((2R)-6-methylhept-5-en-2-yl)-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta(a)phenanthren-3-ol; RefChem:152283; DTXCID9020744; 4,4,14 alpha-trimethyl-5 alpha-cholesta-8,24-dien-3 beta-ol; 201-214-9; Lanster; Botalan base 138; Lanosta-8,24-dienol; Cryptosterol; Lanosta-8,24-dien-3-ol, (3.beta.)-; NSC60677; NSC 60677; Lanosta-8,24-dien-3.beta.-ol; MFCD00021108; (3.beta.)-Lanosta-8,24-dien-3-ol; C30H50O; Isocholesterol; Lanosterol (Technical Grade); Botalan base; Cholesta-8,24-dien-3-ol, 4,4,14-trimethyl-, (3.beta.,5.alpha.)-; (3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-((R)-6-methylhept-5-en-2-yl)-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5R,10S,13R,14R,17R)-17-[(1R)-1,5-dimethylhex-4-enyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; Lanostadien-3-beta-ol; lanostcrol; Lanososterol; Lanostereol; UNII-1J05Z83K3M; Lanosta-8,24-dien-3-beta-ol; EINECS 201-214-9; (3-beta)-Lanosta-8,24-dien-3-ol; Lanosterol - 90%; BRN 2226449; LANOSTEROL [MI]; AI3-23643; 8,24-Lanostadiene-3?-ol; Lanosta-8, (3.beta.)-; Lanosterol, >=93%, powder; SCHEMBL145834; CHEMBL225111; GTPL2746; orb1221329; orb1302406; orb3140811; 3?-Hydroxy-8,24-lanostadiene; GLXC-14819; (3-beta)-lanosta-24-dien-3-ol; Cholesta-8,24-dien-3-ol, 4,4,14-trimethyl-, (3beta,5alpha)-; BDBM50459238; LMST01010017; MSK164264; (3|A)-Lanosta-8,24-dien-3-ol; (3 beta)-Lanosta-8,24-dien-3-ol; (3|_)-Lanosta-8,24-dien-3-ol; AKOS024307002; DB03696; EBC-616124; FL71051; HY-W020033; NCGC00164398-01; (1R,3aR,5aR,7S,9aS,11aR)-3a,6,6,9a,11a-pentamethyl-1-[(2R)-6-methylhept-5-en-2-yl]-1H,2H,3H,3aH,4H,5H,5aH,6H,7H,8H,9H,9aH,10H,11H,11aH-cyclopenta[a]phenanthren-7-ol; FL159528; Lanosta-8,24-dien-3-ol, (3-beta)-; MS-27534; SY046459; (3beta,20R)-Lanosta-8,24-dien-3-ol; CS-0031956; T4970; Lanosterol (Isocholesterol) - Lanosterol 60%; C01724; F979492; Q414996; (3alpha)-4,4,14-trimethyl-Cholesta-8,24-dien-3-ol; (3beta,5alpha)-4,4,14-trimethylcholesta-8,24-dien-3-ol; 4,4,14alpha-trimethyl-5alpha-cholesta-8,24-dien-3beta-ol; C4CA2F34-1C1A-4673-AC43-E547708CB228; Cholesta-8, 4,4,14-trimethyl-, (3.beta.,5.alpha.)-; (3beta,5alpha)-4,4,14-trimethyl-Cholesta-8,24-dien-3-ol; (3S5R10S13R14R17R)-44101314-pentamethyl-17-((R)-6-methylhept-5-en-2-yl)-2345671011121314151617-tetradecahydro-1H-cyclopenta[a]phenanthren-3-olSynonyms